Liraud F, Verdoux H
Université Victor-Segalen Bordeaux 2, CH Charles-Perrens, Centre Carreire, Bordeaux.
Encephale. 2000 May-Jun;26(3):16-23.
The aims of this study were to estimate: 1) the prevalence of substance use disorder, 2) the social and clinical characteristics associated to such a comorbid disorder in patients hospitalised in psychiatry.
Patients consecutively hospitalised for a non-addictive disorder were included in the present survey. A standardised method was used to collect information on clinical and social characteristics. DSM IV diagnoses, including those of substance use, were made using a structured diagnostic interview and all available clinical and historical informations collected during the hospital stay.
We have included 127 patients fulfilling the diagnostic criteria for affective disorders (n = 61), non-affective psychotic disorder (schizophrenia, schizoaffective disorder, delusional disorder, other psychotic disorders, n = 50) and personality disorder (n = 16). Among these patients, 11.8% presented with a current abuse/dependence to alcohol (lifetime prevalence: 25.2%), 11% to cannabis (lifetime prevalence: 22.8%). The lifetime prevalence for any other substance disorder was 2.4%. The subjects presenting with an abuse/dependence to alcohol had a higher rate of psychiatric hospitalisation (OR = 2.9; 95% CI 1.0-8.1; p = 0.04) and had more frequently a history of attempted suicide (OR = 2.6; 95% CI 1.0-6.5; p = 0.04). The cannabis misuse was associated with medication noncompliance (OR = 3.1; 95% CI 1.1-9.1; p = 0.04) and more frequent penal problems (OR = 15.0; 95% CI 2.9-78.7; p = 0.001).
Cannabis and alcohol misuse have a negative, but different, impact on social adaptation and clinical outcome in subjects with psychiatric disorder. These results confirm the necessity to systematically assess this type of comorbid disorder and to distinguish the different substances.
本研究的目的是评估:1)物质使用障碍的患病率;2)在精神病住院患者中,与这种共病障碍相关的社会和临床特征。
本调查纳入了因非成瘾性疾病而连续住院的患者。采用标准化方法收集临床和社会特征信息。使用结构化诊断访谈以及住院期间收集的所有可用临床和病史信息进行《精神疾病诊断与统计手册》第四版(DSM-IV)诊断,包括物质使用诊断。
我们纳入了127例符合情感障碍(n = 61)、非情感性精神障碍(精神分裂症、分裂情感性障碍、妄想性障碍、其他精神障碍,n = 50)和人格障碍(n = 16)诊断标准的患者。在这些患者中,11.8%目前存在酒精滥用/依赖(终生患病率:25.2%),11%存在大麻滥用/依赖(终生患病率:22.8%)。任何其他物质障碍的终生患病率为2.4%。存在酒精滥用/依赖的受试者精神病住院率更高(比值比[OR] = 2.9;95%置信区间[CI] 1.0 - 8.1;p = 0.04),且更频繁地有自杀未遂史(OR = 2.6;95% CI 1.0 - 6.5;p = 0.04)。大麻滥用与药物治疗不依从相关(OR = 3.1;95% CI 1.1 - 9.1;p = 0.04)以及更频繁的刑事问题相关(OR = 15.0;95% CI 2.9 - 78.7;p = 0.001)。
大麻和酒精滥用对精神障碍患者的社会适应和临床结局有负面但不同的影响。这些结果证实了系统评估这类共病障碍并区分不同物质的必要性。